A share price of Syndax Pharmaceuticals Inc [SNDX] is currently trading at $19.69, up 3.96%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SNDX shares have gain 3.20% over the last week, with a monthly amount glided 7.83%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Syndax Pharmaceuticals Inc [NASDAQ: SNDX] stock has seen the most recent analyst activity on October 24, 2024, when UBS initiated its Buy rating and assigned the stock a price target of $37. Previously, Jefferies started tracking the stock with Buy rating on June 28, 2024, and set its price target to $37. On January 31, 2024, downgrade downgraded it’s rating to Sector Perform and revised its price target to $23 on the stock. Mizuho started tracking the stock assigning a Buy rating and suggested a price target of $45 on December 22, 2023. BofA Securities initiated its recommendation with a Buy and recommended $29 as its price target on October 25, 2023. Goldman started tracking with a Buy rating for this stock on October 11, 2023, and assigned it a price target of $30. In a note dated July 27, 2023, Scotiabank initiated an Sector Outperform rating.
Syndax Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $13.14 and $25.34. Currently, Wall Street analysts expect the stock to reach $36.11 within the next 12 months. Syndax Pharmaceuticals Inc [NASDAQ: SNDX] shares were valued at $19.69 at the most recent close of the market. An investor can expect a potential return of 83.39% based on the average SNDX price forecast.
Analyzing the SNDX fundamentals
Gross Profit Margin for this corporation currently stands at -10.05% with Operating Profit Margin at -71.36%, Pretax Profit Margin comes in at -65.43%, and Net Profit Margin reading is -65.43%. To continue investigating profitability, this company’s Return on Assets is posted at -0.55, Equity is -0.57 and Total Capital is -0.66. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 19.03 points at the first support level, and at 18.36 for the second support level. However, for the 1st resistance point, the stock is sitting at 20.08, and for the 2nd resistance point, it is at 20.46.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Syndax Pharmaceuticals Inc [NASDAQ:SNDX] is 10.50. As well, the Quick Ratio is 10.50, while the Cash Ratio is 2.48. Considering the valuation of this stock, the price to sales ratio is 478.73, the price to book ratio is 3.85.
Transactions by insiders
Recent insider trading involved Goldan Keith A., Chief Financial Officer, that happened on Jun 14 ’24 when 1250.0 shares were purchased.
